JQDN

General

Low Serum Creatinine As A Prognostic Marker In Advanced Cancer

Di: Stella

Thus limitations linked to serum creatinine dosage cannot be applied in AKI. Also, Finally, an early diagnosis by repeated dosages of creatinine level is necessary for a specific

(PDF) Serum creatinine/cystatin C ratio is a systemic marker of ...

Background It is well known that sarcopenia is a common risk factor in patients with gastrointestinal tumours, which may negatively affect the clinical outcome and prognosis.

We conducted a similar study to assess the role of NLR as a prognostic marker in locally advanced head and neck cancer (HNC) treated with chemoradiation.

Serum creatinine in cirrhotic patients: a cornerstone

High serum creatinine was associated with shorter survival than normal creatinine, while low serum creatinine was not. Conclusions Low serum creatinine levels did not have an important The serum creatinine (Cr)/cystatin C (CysC) ratio has been proposed as a marker of sarcopenia, given its correlation with total skeletal muscle mass, and as a prognostic

Background Sarcopenia is a poor prognostic factor in cancer patients. In recent years, there have been reports that serum creatinine and cystatin C (Cr/CysC) ratio is Background Sarcopenia is an important prognostic factor of lung cancer. The serum creatinine/cystatin C ratio (CCR) and the sarcopenia index (SI, serum creatinine × Purpose The purpose of this study was to investigate the predictive value of changes in serum uric acid (SUA), the ratio of serum uric acid to serum creatinine (SUA/SCr),

Conclusions Pre-treatment circulating levels of serum IL-6, HGF, and CCR may serve as independent predictive and prognostic biomarkers in advanced cancer patients

Background & aims Sarcopenia is associated with poor clinical outcomes of patients who underwent esophagectomy. The current diagnostic criteria for sarcopenia are

Background Sarcopenia is an age-related syndrome that may have negative impact on surgical outcomes and long-term survival of patients with gastric cancer. Serum

Hypoalbuminemia is a strong, reliable and independent prognostic marker in these populations [5]. Low serum albumin functions independently from confounders such as Among cancer patients, pancreatic cancer C ratio CCR has patients have the highest rate of sarcopenia, which is a critical prognostic factor. Serum creatine kinase (CK) is closely related to skeletal muscle mass and has been reported to decline with

Sarcopenia represents one of the hallmarks of all chronic diseases, including cancer, and was already investigated as a prognostic marker in the pre-immunotherapy era.

This study evaluates the prognostic and diagnostic significance of poliovirus receptor (PVR) gene expression and protein levels, serum amylase, and urinary biomarkers Low and high albumin functions independently from confounders serum creatinine levels were significantly associated with poor survival in patients with cancer at the end-of-life stage. Therefore, readily available and simple biomarkers may

Cancers | Free Full-Text | C-Reactive Protein Is a Potential Prognostic ...

Background Among cancer patients, pancreatic cancer patients have the highest rate of sarcopenia, which is a critical prognostic factor. Serum creatine kinase (CK) is closely Biomarkers are vital in healthcare as they provide valuable insights into disease diagnosis, prognosis, treatment response, and personalized medicine. They serve as objective indicators, Background At present, although there are some known molecular markers for the prognosis of non-small cell lung cancer (NSCLC) brain metastases, but there are still shortcomings in

Background: Sarcopenia is an important prognostic factor of lung cancer. The serum creatinine/cystatin C ratio (CCR) and the sarcopenia index (SI, serum creatinine × cystatin C Sarcopenia is a well-known risk factor for inferior cancer outcomes, but the identification of patients at risk remains challenging. A new sarcopenia index (SI), defined as Background: Creatinine-to-cystatin C ratio (CCR) and body composition (BC) parameters have emerged as significant prognostic factors in cancer patients. However, the

One of the most favorable aspects of using serum creatinine for GFR estimation, in comparison with other markers of kidney function, is its worldwide availability and low cost.

To evaluate the prognostic value of C-reactive protein (CRP), albumin, CRP/albumin ratio (CAR), and modified Glasgow Prognostic Score (mGPS) at different

Background Muscle wasting is prevalent in cancer patients, and early recognition of this phenomenon is important for risk stratification. Recent studies have suggested that the

Lactate dehydrogenase (LDH) is widely accepted as a prognostic marker in a range of advanced solid tumors, including NSCLC. 8 – 10 As a marker of systemic inflammation Purpose Low serum creatinine/cystatin C ratio (CCR) is associated with unfavorable characteristics in patients with chronic obstructive pulmonary disease (COPD);

This study evaluated the usefulness of the serum creatinine/cystatin C (Cr/CysC) ratio as a prognostic factor after pancreatic surgery in patients with pancreatic cancer. The

CAR has been recently used as a new prognostic marker in COVID-19 32, severe fever with thrombocytopenia syndrome (SFTS) 33, and cardiac arrest 34. Abstract Aim: To evaluate preoperative serum creatinine level as a prognostic parameter in patients with primary epithelial ovarian cancer (EOC).

Therefore, leveraging the characteristics of these two markers ratio, the serum creatinine/cystatin C ratio (CCR) has been served as an alternative biomarker of sarcopenia and prognostic factor Introduction Colorectal cancer (CRC) rankse abdominal wall is a rare disease. We aim to elucidate the clinical and prognostic characteristics of this disease. Background Previous studies have shown that the albumin-to-creatinine ratio (ACR) is associated with the prognosis of patients with liposarcoma. However, the role of ACR

Serum creatinine and cystatin C are widely used in clinical practice to assess renal function. And the ratio of the two markers (serum creatinine/serum cystatin C) x100, known as CCR, has recently attracted interest. In 2016, Aim: To evaluate preoperative serum creatinine level as a prognostic parameter in patients with primary epithelial ovarian cancer (EOC). Patients and Methods: In a retrospective cohort study,